Alembic Limited announced that Mr. C. P. Buch has completed his second consecutive term of five years as an Independent Director and consequently ceases to be a Director of the Company with effect from end of the day on 31st March, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.08 INR | +0.89% | -4.05% | -1.69% |
04-18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
04-02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
1st Jan change | Capi. | |
---|---|---|
-1.69% | 272M | |
+36.64% | 29.21B | |
+4.11% | 28.04B | |
-12.67% | 27.86B | |
+17.36% | 25.39B | |
+47.76% | 24.16B | |
+5.81% | 20.93B | |
+3.41% | 19.25B | |
+26.99% | 16.61B | |
-14.16% | 15.42B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Announces Cessation of C. P. Buch as an Independent Director